Crossmark

The double edge of anti-CD40 siRNA therapy: It increases renal microcapillar density but favours the generation of an inflammatory milieu in the kidneys of ApoE−/− mice

Crossref DOI link: https://doi.org/10.1186/s12950-019-0228-9

Published Online: 2019-12-16

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hueso, Miguel https://orcid.org/0000-0002-1824-9141
Casas, Angela

Mallén, Adrian

de Ramón, Laura

Bolaños, Nuria

Varela, Cristian

Cruzado, Josep M.

Torras, Joan

Navarro, Estanislao
Funding

Funding for this research was provided by:

Instituto de Salud Carlos III (PI 18/01108)
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-16
More Information

Article History

Received: 15 April 2019

Accepted: 27 November 2019

First Online: 16 December 2019

Ethics approval

: Animal care and the protocols were approved by the ethics committee for animal research of the University of Barcelona-HUB.

: N/A.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below